AI Analysis

How does 6496.TWO make money? Does 6496.TWO have pricing power? What's the Earnings Whisper? Will 6496.TWO profit more as the business scales? What is 6496.TWO's management track record? Is 6496.TWO's current price justified?

Excelsior Biopharma Inc.

TWD 24.65 -$4.50 (-15.44%)

TWO · 16 Sep 2026 05:22 UTC

Previous Close

TWD 24.7

Day Range

TWD 24.05TWD 24.65

Year Range

TWD 22.5TWD 30.55

Market Cap

1.15B

AVG Volume

13.89K

Trailing/Forward PE

-5.54/-

PEG ratio

0.14

Dividend Yield

Next Earnings Date

Primary Exchange

Taipei Exchange

Revenue (TWD) · TTM

6496.TWO Revenue (TWD) · TTM by quarter
Period	Revenue (TWD) · TTM
26 Q2	936.92M
26 Q1	906.42M
25 Q4	898.26M
25 Q3	859.77M
25 Q2	870.82M
25 Q1	881.71M
24 Q4	861.91M
24 Q3	830.35M
24 Q2	798.69M
24 Q1	773.69M

Net Income (TWD) · TTM

6496.TWO Net Income (TWD) · TTM by quarter
Period	Net Income (TWD) · TTM
26 Q2	-206.58M
26 Q1	-197.05M
25 Q4	-183.17M
25 Q3	-165.68M
25 Q2	-132.87M
25 Q1	-105.89M
24 Q4	-98.7M
24 Q3	-70.69M
24 Q2	-85.55M
24 Q1	-100.78M

Operating Income (TWD) · TTM

6496.TWO Operating Income (TWD) · TTM by quarter
Period	Operating Income (TWD) · TTM
26 Q2	-199.66M
26 Q1	-187.41M
25 Q4	-171.06M
25 Q3	-152.75M
25 Q2	-119.4M
25 Q1	-88.99M
24 Q4	-82.84M
24 Q3	-56.71M
24 Q2	-71.03M
24 Q1	-85.56M

EBITDA (TWD) · TTM

6496.TWO EBITDA (TWD) · TTM by quarter
Period	EBITDA (TWD) · TTM
26 Q2	-127.98M
26 Q1	-109.7M
25 Q4	-92.9M
25 Q3	-77.3M
25 Q2	-41.67M
25 Q1	-15.25M
24 Q4	-8.86M
24 Q3	15.38M
24 Q2	-942K
24 Q1	-27.84M

Cash Flows (TWD) · TTM

6496.TWO Cash Flows (TWD) · TTM by quarter
Period	Cash Flows (TWD) · TTM
26 Q2	-162.02M
26 Q1	-138.52M
25 Q4	-174.53M
25 Q3	-223.15M
25 Q2	-211.26M
25 Q1	-235.85M
24 Q4	-356.95M
24 Q3	-337.27M
24 Q2	-307.39M
24 Q1	-323.54M

EPS (TWD) · TTM

6496.TWO EPS (TWD) · TTM by quarter
Period	EPS (TWD) · TTM
26 Q2	-4.45
26 Q1	-4.25
25 Q4	-3.96
25 Q3	-3.58
25 Q2	-2.87
25 Q1	-2.3
24 Q4	-2.14
24 Q3	-1.54
24 Q2	-1.87
24 Q1	-2.2

Expenses (TWD) · TTM

6496.TWO Expenses (TWD) · TTM by quarter
Period	Expenses (TWD) · TTM
26 Q2	529.06M
26 Q1	538.4M
25 Q4	554.2M
25 Q3	553.08M
25 Q2	568.42M
25 Q1	555.51M
24 Q4	717.97M
24 Q3	687.09M
24 Q2	660.69M
24 Q1	632.63M

Shares Outstanding · TTM

6496.TWO Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
26 Q2	-79K
26 Q1	-136K
25 Q4	-193K
25 Q3	-182K
25 Q2	-241K
25 Q1	-286K
24 Q4	-331K
24 Q3	-364K
24 Q2	-393K
24 Q1	-328K

Dividends (TWD)

6496.TWO Dividends (TWD) by quarter
Period	Dividends (TWD)
Jul 21	1
Jul 20	1
Jul 19	4
Jul 18	4
Jul 17	3
Aug 16	2.5
Jul 15	2.5

Free Cash Flow Yield

6496.TWO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-12.07%
Sep 26	-12.09%
Sep 26	-12.19%
Aug 26	-12.12%
Aug 26	-12.32%
Aug 26	-12.32%
Aug 26	-12.24%
Jul 26	-12.12%
Jul 26	-12.32%
Jul 26	-12.04%
Jul 26	-11.76%
Jul 26	-12.32%
Jun 26	-14.96%
Jun 26	-15.2%
Jun 26	-15.51%
Jun 26	-15.6%
May 26	-16.56%
May 26	-15.54%
May 26	-15.9%
May 26	-15.48%
Apr 26	-14.96%
Apr 26	-14.9%
Apr 26	-14.33%
Apr 26	-14.2%
Apr 26	-14.25%
Mar 26	-17.85%
Mar 26	-18.6%
Mar 26	-17.91%
Mar 26	-17.88%
Feb 26	-17.81%
Feb 26	-18.39%
Feb 26	-17.98%
Jan 26	-17.49%
Jan 26	-17.15%
Jan 26	-16.09%
Jan 26	-16.53%
Jan 26	-16.59%
Dec 25	-15.6%
Dec 25	-15.39%
Dec 25	-15.6%
Dec 25	-15.42%
Nov 25	-15.6%
Nov 25	-15.55%
Nov 25	-15.57%
Nov 25	-15.74%
Oct 25	-15.71%
Oct 25	-15.71%
Oct 25	-15.26%
Oct 25	-16.04%
Oct 25	-15.52%
Sep 25	-17.59%
Sep 25	-17.44%
Sep 25	-17.01%
Sep 25	-17.18%
Aug 25	-17.84%
Aug 25	-18.03%
Aug 25	-18.41%
Aug 25	-18.58%
Aug 25	-19.76%
Jul 25	-20.15%
Jul 25	-19.42%
Jul 25	-21.72%
Jul 25	-21.23%
Jun 25	-31.57%
Jun 25	-31.38%
Jun 25	-30.16%
Jun 25	-31.51%
May 25	-30.52%
May 25	-30.22%
May 25	-30.16%
May 25	-30.16%
May 25	-28.76%
Apr 25	-29.19%
Apr 25	-28.76%
Apr 25	-31.32%
Apr 25	-27.19%
Mar 25	-25.2%
Mar 25	-24.86%
Mar 25	-24.94%
Mar 25	-24.08%
Feb 25	-23.15%
Feb 25	-21.41%
Feb 25	-22.13%
Feb 25	-21.86%
Jan 25	-22.58%
Jan 25	-22.93%
Jan 25	-22.3%
Jan 25	-22.68%
Dec 24	-22.35%
Dec 24	-22.46%
Dec 24	-22.54%
Dec 24	-22.28%
Nov 24	-22.57%
Nov 24	-22.8%
Nov 24	-22.84%
Nov 24	-22.31%
Nov 24	-22.35%
Oct 24	-22.42%
Oct 24	-23.08%
Oct 24	-22.57%

Price to Sales

6496.TWO Price to Sales by quarter
Period	Price to Sales
Sep 26	1.27
Sep 26	1.26
Sep 26	1.25
Aug 26	1.26
Aug 26	1.24
Aug 26	1.24
Aug 26	1.25
Jul 26	1.26
Jul 26	1.24
Jul 26	1.27
Jul 26	1.3
Jul 26	1.24
Jun 26	1.3
Jun 26	1.28
Jun 26	1.25
Jun 26	1.25
May 26	1.17
May 26	1.25
May 26	1.22
May 26	1.26
Apr 26	1.3
Apr 26	1.3
Apr 26	1.36
Apr 26	1.37
Apr 26	1.36
Mar 26	1.45
Mar 26	1.4
Mar 26	1.45
Mar 26	1.45
Feb 26	1.46
Feb 26	1.41
Feb 26	1.44
Jan 26	1.48
Jan 26	1.51
Jan 26	1.61
Jan 26	1.57
Jan 26	1.56
Dec 25	1.55
Dec 25	1.58
Dec 25	1.55
Dec 25	1.57
Nov 25	1.55
Nov 25	1.56
Nov 25	1.56
Nov 25	1.54
Oct 25	1.54
Oct 25	1.54
Oct 25	1.59
Oct 25	1.51
Oct 25	1.56
Sep 25	1.52
Sep 25	1.53
Sep 25	1.57
Sep 25	1.56
Aug 25	1.5
Aug 25	1.48
Aug 25	1.45
Aug 25	1.44
Aug 25	1.35
Jul 25	1.33
Jul 25	1.38
Jul 25	1.23
Jul 25	1.26
Jun 25	1.31
Jun 25	1.32
Jun 25	1.37
Jun 25	1.31
May 25	1.36
May 25	1.37
May 25	1.37
May 25	1.37
May 25	1.44
Apr 25	1.42
Apr 25	1.44
Apr 25	1.32
Apr 25	1.52
Mar 25	1.61
Mar 25	1.63
Mar 25	1.63
Mar 25	1.69
Feb 25	1.75
Feb 25	1.9
Feb 25	1.84
Feb 25	1.86
Jan 25	1.8
Jan 25	1.77
Jan 25	1.82
Jan 25	1.79
Dec 24	1.72
Dec 24	1.71
Dec 24	1.71
Dec 24	1.73
Nov 24	1.7
Nov 24	1.69
Nov 24	1.69
Nov 24	1.72
Nov 24	1.72
Oct 24	1.72
Oct 24	1.67
Oct 24	1.7

EV/EBITDA

6496.TWO EV/EBITDA by quarter
Period	EV/EBITDA
Mar 25	94.89
Mar 25	96.1
Mar 25	95.79
Mar 25	98.97
Feb 25	102.59
Feb 25	110.3
Feb 25	106.97
Feb 25	108.18
Jan 25	105.01
Jan 25	103.5
Jan 25	106.22
Jan 25	104.56

Price to Book

6496.TWO Price to Book by quarter
Period	Price to Book
Sep 26	1.54
Sep 26	1.54
Sep 26	1.52
Aug 26	1.53
Aug 26	1.51
Aug 26	1.51
Aug 26	1.52
Jul 26	1.53
Jul 26	1.51
Jul 26	1.54
Jul 26	1.58
Jul 26	1.51
Jun 26	1.45
Jun 26	1.43
Jun 26	1.4
Jun 26	1.39
May 26	1.31
May 26	1.4
May 26	1.37
May 26	1.4
Apr 26	1.45
Apr 26	1.46
Apr 26	1.51
Apr 26	1.53
Apr 26	1.52
Mar 26	1.48
Mar 26	1.42
Mar 26	1.47
Mar 26	1.47
Feb 26	1.48
Feb 26	1.43
Feb 26	1.47
Jan 26	1.51
Jan 26	1.54
Jan 26	1.64
Jan 26	1.59
Jan 26	1.59
Dec 25	1.51
Dec 25	1.53
Dec 25	1.51
Dec 25	1.53
Nov 25	1.51
Nov 25	1.52
Nov 25	1.51
Nov 25	1.5
Oct 25	1.5
Oct 25	1.5
Oct 25	1.54
Oct 25	1.47
Oct 25	1.52
Sep 25	1.41
Sep 25	1.42
Sep 25	1.46
Sep 25	1.45
Aug 25	1.39
Aug 25	1.38
Aug 25	1.35
Aug 25	1.34
Aug 25	1.26
Jul 25	1.23
Jul 25	1.28
Jul 25	1.14
Jul 25	1.17
Jun 25	1.14
Jun 25	1.15
Jun 25	1.19
Jun 25	1.14
May 25	1.18
May 25	1.19
May 25	1.19
May 25	1.19
May 25	1.25
Apr 25	1.23
Apr 25	1.25
Apr 25	1.15
Apr 25	1.32
Mar 25	1.31
Mar 25	1.33
Mar 25	1.32
Mar 25	1.37
Feb 25	1.43
Feb 25	1.54
Feb 25	1.49
Feb 25	1.51
Jan 25	1.46
Jan 25	1.44
Jan 25	1.48
Jan 25	1.46
Dec 24	1.32
Dec 24	1.31
Dec 24	1.31
Dec 24	1.32
Nov 24	1.3
Nov 24	1.29
Nov 24	1.29
Nov 24	1.32
Nov 24	1.32
Oct 24	1.31
Oct 24	1.28
Oct 24	1.3

No video analysis for this stock yet. Request one from our team.

AI Analysis

Excelsior Biopharma Inc.

Video analysis: 6496.TWO

Similar companies